[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2009/48189,2009,A1Locationinpatent:Page/Pagecolumn45
[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2006/111311,2006,A1Locationinpatent:Page/Pagecolumn17
[3]Eldrup,AnneB.;Prhavc,Marija;Brooks,Jennifer;Bhat,Balkrishen;Prakash,ThazhaP.;Song,Quanlai;Bera,Sanjib;Bhat,Neelima;Dande,Prasad;Cook,P.Dan;Bennett,C.Frank;Carroll,StevenS.;Ball,RichardG.;Bosserman,Michele;Burlein,Christine;Colwell,LawrenceF.;Fay,JohnF.;Flores,OsvaldoA.;Getty,Krista;LaFemina,RobertL.;Leone,Joseph;MacCoss,Malcolm;McMasters,DanielR.;Tomassini,JoanneE.;VonLangen,Derek;Wolanski,Bohdan;Olsen,DavidB.[JournalofMedicinalChemistry,2004,vol.47,#21,p.5284-5297]
[4]CurrentPatentAssignee:IONISPHARMACEUTICALS-WO2003/99840,2003,A1Locationinpatent:Page156-157
[5]CurrentPatentAssignee:Olsen,DavidB.;Tomassini,JoanneE.;Mao,Shi-Shan;Carroll,StevenS.-US2004/259934,2004,A1Locationinpatent:Page/Pagecolumn14
[6]CurrentPatentAssignee:IONISPHARMACEUTICALS;MERCK&COINC-US2017/183373,2017,A1Locationinpatent:Paragraph0786;0787;0788;0789
[1]Eldrup,AnneB.;Prhavc,Marija;Brooks,Jennifer;Bhat,Balkrishen;Prakash,ThazhaP.;Song,Quanlai;Bera,Sanjib;Bhat,Neelima;Dande,Prasad;Cook,P.Dan;Bennett,C.Frank;Carroll,StevenS.;Ball,RichardG.;Bosserman,Michele;Burlein,Christine;Colwell,LawrenceF.;Fay,JohnF.;Flores,OsvaldoA.;Getty,Krista;LaFemina,RobertL.;Leone,Joseph;MacCoss,Malcolm;McMasters,DanielR.;Tomassini,JoanneE.;VonLangen,Derek;Wolanski,Bohdan;Olsen,DavidB.[JournalofMedicinalChemistry,2004,vol.47,#21,p.5284-5297]
[2]CurrentPatentAssignee:IONISPHARMACEUTICALS-WO2003/99840,2003,A1Locationinpatent:Page193-194
[3]CurrentPatentAssignee:IONISPHARMACEUTICALS;MERCK&COINC-US2017/183373,2017,A1Locationinpatent:Paragraph0985;0986;0987;0988
[1]Eldrup,AnneB.;Prhavc,Marija;Brooks,Jennifer;Bhat,Balkrishen;Prakash,ThazhaP.;Song,Quanlai;Bera,Sanjib;Bhat,Neelima;Dande,Prasad;Cook,P.Dan;Bennett,C.Frank;Carroll,StevenS.;Ball,RichardG.;Bosserman,Michele;Burlein,Christine;Colwell,LawrenceF.;Fay,JohnF.;Flores,OsvaldoA.;Getty,Krista;LaFemina,RobertL.;Leone,Joseph;MacCoss,Malcolm;McMasters,DanielR.;Tomassini,JoanneE.;VonLangen,Derek;Wolanski,Bohdan;Olsen,DavidB.[JournalofMedicinalChemistry,2004,vol.47,#21,p.5284-5297]
[2]CurrentPatentAssignee:IONISPHARMACEUTICALS-WO2003/99840,2003,A1Locationinpatent:Page194-195
[3]CurrentPatentAssignee:IONISPHARMACEUTICALS;MERCK&COINC-US2017/183373,2017,A1Locationinpatent:Paragraph0989;0990;0991;0992
[1]Bio,MatthewM.;Xu,Feng;Waters,Marjorie;Williams,J.Michael;Savary,KimberlyA.;Cowden,CameronJ.;Yang,Chunhua;Buck,Elizabeth;Song,ZhiguoJ.;Tschaen,DavidM.;Volante;Reamer,RobertA.;Grabowski,EdwardJ.J.[JournalofOrganicChemistry,2004,vol.69,#19,p.6257-6266]
[1]Bio,MatthewM.;Xu,Feng;Waters,Marjorie;Williams,J.Michael;Savary,KimberlyA.;Cowden,CameronJ.;Yang,Chunhua;Buck,Elizabeth;Song,ZhiguoJ.;Tschaen,DavidM.;Volante;Reamer,RobertA.;Grabowski,EdwardJ.J.[JournalofOrganicChemistry,2004,vol.69,#19,p.6257-6266]
Title: Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.
Journal: Bioorganic & medicinal chemistry letters 20130401
Title: Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.
Journal: Bioorganic & medicinal chemistry 20120801
Title: Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20120615
Title: Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.
Journal: Journal of hepatology 20110501
Title: Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.
Journal: Antimicrobial agents and chemotherapy 20090301
Title: Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2'-C-methyladenosine.
Journal: Bioorganic & medicinal chemistry 20070801
Title: A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
Journal: The Journal of infectious diseases 20070301
Title: Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.
Journal: Journal of medicinal chemistry 20041007
Title: Carroll SS, et al. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees. Antimicrob Agents Chemother. 2009 Mar;53(3):926-34.
